landiolol has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, N; Hanada, K; Higuma, T; Kushibiki, M; Nishizaki, F; Oikawa, K; Okumura, K; Osanai, T; Saito, S; Sukekawa, T; Tomita, H; Yamada, M; Yokota, T | 1 |
| Yoshiyama, M | 1 |
1 trial(s) available for landiolol and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Adrenergic beta-1 Receptor Antagonists; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Female; Humans; Injections, Intravenous; Male; Middle Aged; Morpholines; Myocardial Infarction; Prospective Studies; Stroke Volume; Treatment Outcome; Urea; Ventricular Remodeling | 2012 |
1 other study(ies) available for landiolol and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effect and safety of landiolol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Female; Humans; Male; Morpholines; Myocardial Infarction; Urea; Ventricular Remodeling | 2012 |